Skip to main content
Clinical Trials/ACTRN12611000434998
ACTRN12611000434998
Not Yet Recruiting
Phase 2

A randomised controlled trial to explore the effects of oxytocin/placebo on eye gaze in adults who stutter.

niversity of Sydney0 sites40 target enrollmentApril 27, 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Stuttering
Sponsor
niversity of Sydney
Enrollment
40
Status
Not Yet Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 27, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male adults who stutter
  • Onset of stuttering before 12 years of age
  • No treatment for stuttering or anxiety conditions within 6 months preceding the experimental procedure

Exclusion Criteria

  • Onset of stuttering at age 12 years or older
  • Onset of stuttering due to a known conversion or any other psychological disorder
  • Presence of a complicating disorder (e.g., developmental delay, autism, Down’s Syndrome, cerebral palsy etc.)
  • Currently taking ‘psychological’ medication
  • Severe Depression with suicidal thoughts and/ or actions
  • Severe Cardiovascular problems (e.g., heart disease, history of heart attacks)
  • Kidney Disease\- (i.e., kidney stones, recurrent bladder infections, or known kidney failure)
  • Psychosis (i.e., bizarre beliefs that do not represent reality; sensations without any sensory input\- hearing, smelling seeing, feeling things that don’t exist.
  • Drugs: Smoking more than 15 cigarettes a day or addicted to other illegal substances.
  • Sensitivity to preservatives (in particular E 216, E 218 and chlorobutanol hemihydrate)

Outcomes

Primary Outcomes

Not specified

Similar Trials